[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_4871 

# __Genomic sequencing__

## Risks linked to this technology

* [Assumption of short-term immunity after recovery](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_4053.md)
* [Bats as native host of covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5415.md)
* [Comparison of sars-cov-2 with sars-cov-1](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6083.md)
* [Development of new drugs and antibodies may not cover all variations of the human coronavirus, leading to gaps in treatment options.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6177.md)
* [Discovery of virus with genomic similarity to sars-cov-2 raises concerns about potential for human transmission.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6417.md)
* [Evolution of virus and development of mutant variants complicating prediction of covid-19 incidence and outcomes.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6820.md)
* [Identification of patient zero](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6836.md)
* [Inability to assess seasonal patterns and mutated versions of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7306.md)
* [Lack of detailed viral surveillance at the genomic level](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8513.md)
* [Lack of historical data for new virus transmission, incubation period, and immunity duration.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8696.md)
* [Mutations leading to increased infectivity and immune evasion](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10585.md)
* [New variant of covid-19 driving increased transmission](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10768.md)
* [New, more transmissible variants of the sars-cov-2 virus may require a review of current efforts to suppress the spread of covid-19.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10781.md)
* [Poor understanding of sars-cov-2 transmission patterns and the impact of interventions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10802.md)
* [Poor understanding of the incubation period and duration of infectious period for covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10803.md)
* [Potential exponential growth of voc from 0% to 46% nationally in a short timeframe](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12427.md)
* [Presence of sars-cov-2 in wastewater](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13318.md)
* [Rapid variation of some viruses](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13418.md)
* [Risk of new variants and mutations](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13610.md)
* [Superspreading events leading to majority transmission of covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13650.md)
* [Uncertainty in transmission and infection nature of covid-19, including potential for new, more transmissible variants](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13660.md)
* [Unclear source and intermediate hosts of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16435.md)
* [Underfunding of global surveillance of viruses capable of transmission to humans](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18141.md)
* [Unknown and novel viruses with similar patterns and symptoms may emerge in the future, leading to the possibility of facing another pandemic.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18143.md)
* [Unknown and sudden nature of the virus](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18186.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Sequencing and genomic analysis](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_8.md)

## This technology is mentioned by

* [Aloulou_design_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_609.md)
* [Bayoudhi_overview_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_426.md)
* [Burridge_ventilation_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_411.md)
* [Cao_analysis_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_443.md)
* [Channa_rise_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_466.md)
* [Chen_climate_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_509.md)
* [Collin_using_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_429.md)
* [Fawzy_covid-19_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_392.md)
* [Ferguson_report_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_551.md)
* [Mehta_pandemic_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_528.md)
* [Pilati_digital_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_507.md)
* [Syal_learning_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_432.md)
* [Thukral_covid19_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_544.md)
* [Tian_investigation_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_546.md)
* [Van_doremalen_aerosol_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_646.md)
* [Wu_current_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_469.md)
* [Wu_sars-cov-2_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_501.md)
* [Zhang_effective_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_433.md)

